BETHANECHOL CHLORIDE description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

BETHANECHOL CHLORIDE

Rising Pharmaceuticals Inc.
Emcure Pharmaceuticals Ltd.

Bethanechol Chloride Tablets USP


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BETHANECHOL CHLORIDE DESCRIPTION




71722
BETHANECHOL CHLORIDE


CLINICAL PHARMACOLOGY












INDICATIONS & USAGE


Bethanechol chloride is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.

BETHANECHOL CHLORIDE CONTRAINDICATIONS




PRECAUTIONS

General


In urinary retention, if the sphincter fails to relax as bethanechol contracts the bladder, urine may be forced up the ureter into the kidney pelvis. If there is bacteriuria, this may cause reflux infection.

Information for Patients


Bethanechol chloride tablets should preferably be taken one hour before or two hours after meals to avoid nausea or vomiting. Dizziness, lightheadedness or fainting may occur, especially when getting up from a lying or sitting position.

Drug Interactions


Carcinogenesis & Mutagenesis & Impairment Of Fertility


Pregnancy



Nursing Mothers


Pediatric Use


BETHANECHOL CHLORIDE ADVERSE REACTIONS




Body as a Whole:Digestive:Renal:Nervous System:Cardiovascular:Skin:Special Senses:

Causal Relationship Unknown:
Body as a Whole:Nervous System:

OVERDOSAGE




Atropine Sulfate is a specific antidote.


DOSAGE & ADMINISTRATION








OVERDOSAGE

HOW SUPPLIED




















PACKAGE LABEL.PRINCIPAL DISPLAY PANEL



















BETHANECHOL CHLORIDE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL





















BETHANECHOL CHLORIDE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL




















BETHANECHOL CHLORIDE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL





















BETHANECHOL CHLORIDE

BETHANECHOL CHLORIDE

BETHANECHOL CHLORIDE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:64980-160
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BETHANECHOL CHLORIDE BETHANECHOL 5 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
SILICON DIOXIDE
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM STARCH GLYCOLATE TYPE A POTATO
povidone

Product Characteristics

Color Size Imprint Code Shape
WHITE 6 mm EP118 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:64980-160-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091256 2010-08-24


BETHANECHOL CHLORIDE

BETHANECHOL CHLORIDE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:64980-161
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BETHANECHOL CHLORIDE BETHANECHOL 10 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
SILICON DIOXIDE
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM STARCH GLYCOLATE TYPE A POTATO
povidone

Product Characteristics

Color Size Imprint Code Shape
WHITE 8 mm EP119 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:64980-161-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091256 2010-04-06


BETHANECHOL CHLORIDE

BETHANECHOL CHLORIDE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:64980-162
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BETHANECHOL CHLORIDE BETHANECHOL 25 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
SILICON DIOXIDE
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM STARCH GLYCOLATE TYPE A POTATO
povidone

Product Characteristics

Color Size Imprint Code Shape
WHITE 9 mm EP120 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:64980-162-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091256 2010-04-06


BETHANECHOL CHLORIDE

BETHANECHOL CHLORIDE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:64980-163
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
BETHANECHOL CHLORIDE BETHANECHOL 50 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
SILICON DIOXIDE
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM STARCH GLYCOLATE TYPE A POTATO
povidone

Product Characteristics

Color Size Imprint Code Shape
WHITE 11 mm EP121 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:64980-163-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091256 2010-04-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.